AKT1 and hepatocellular carcinoma: Furthermore, the BrdU staining of murine hepatocytes confirmed that FAK deficiency in a MET/CAT-driven HCC decreased cell proliferation and concomitantly reduced the activation of Akt and ERK1/2 proteins, main actors of molecular pathways driving cell proliferation [62].